Skip to content

Evaluation-based randomized parallel controlled study of simplified cognitive behavioral therapy for insomnia (CBTI-S) for residual sleep symptoms in patients with depression

Evaluation-based randomized parallel controlled study of simplified cognitive behavioral therapy for insomnia (CBTI-S) for residual sleep symptoms in patients with depression

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000036936
Enrollment
Unknown
Registered
2020-08-25
Start date
2020-12-01
Completion date
Unknown
Last updated
2020-09-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

depression and insomnia

Interventions

control group:Conventional drug therapy + psychological education
experimental group:Conventional drug therapy +simplified cognitive behavioral therapy

Sponsors

Shanghai Mental Health Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) aged >= 18 years, male and female; 2) meet the diagnostic criteria of DSM-5 fordepression, the current 14 = 10; 4) may be accompanied by anxiety symptoms, but currently does not meet any anxiety disorders diagnostic criteria,14 <= HAMA <= 29; 5) have sufficient education and understanding to complete this study to be examined and evaluated; 6) voluntary participation in this clinical trial and signature of informed consent.

Exclusion criteria

Exclusion criteria: 1) DSM-5 other sleep problems, such as apnea syndrome, restless leg syndrome; 2) exclude women who are pregnant, nursing or planning to become pregnant during the study; 3) insomnia caused by alcohol or substance abuse; 4) severe cognitive problems; 5) obvious negative risk, HAMD-17 article 2 score >= 3; 6) patients who have been or are currently diagnosed with bipolar and related disorders, coercion and related disorders, schizophrenia spectrum and other psychiatric disorders, trauma and stress-related disorders, separation disorders, eating disorders; 7) exclude patients with history of epilepsy or other serious somatic diseases; 8) exclude persons receiving MECT treatment for nearly one month; 9) excluding those who have received systemic psychotherapy for more than 3 months in a row; 10) the researchers believe that it is not suitable to participate in this clinical study.

Design outcomes

Primary

MeasureTime frame
SE;decrease of depressive symptoms;

Countries

China

Contacts

Public ContactYuan Chengmei

Shanghai Mental Health Center

yuanchengmei@yeah.net+86 13818132592

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026